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Chronic infantile neurological cutaneous and articular (CINCA) syndrome is a severe chronic inflammatory disease
of early onset, characterized by cutaneous symptoms, central-nervous-system involvement, and arthropathy. In the
present study, we report, in seven unrelated patients with CINCA syndrome, distinct missense mutations within
the nucleotide-binding site of CIAS1, a gene encoding cryopyrin and previously shown to cause Muckle-Wells
syndrome and familial cold urticaria. Because of the severe cartilage overgrowth observed in some patients with
CINCA syndrome and the implications of polymorphonuclear cell infiltration in the cutaneous and neurological
manifestations of this syndrome, the tissue-specific expression of CIAS1 was evaluated. A high level of expression
of CIAS1 was found to be restricted to polymorphonuclear cells and chondrocytes. These findings demonstrate
that CIAS1 missense mutations can result in distinct phenotypes with only a few overlapping symptoms and suggest
that this gene may function as a potential inducer of apoptosis.
Chronic infantile neurological cutaneous and articular
(CINCA) syndrome, also known as “neonatal onset mul-
tisystemic inflammatory disease,” is a rare congenital in-
flammatory disorder characterized by a triad of (1) neo-
natal onset of cutaneous symptoms, (2) chronic men-
ingitis, and (3) joint manifestations with recurrent fever
and inflammation (Prieur and Griscelli 1981; Hassink and
Goldsmith 1983; Prieur et al. 1987; Torbiak et al. 1989;
Prieur 2001). Persistent and migratory skin rash associ-
ated with skin perivascular polymorphonuclear infiltrates
is present in patients, starting at birth. A progressive neu-
rological impairment results from chronic meningitis
caused by polymorphonuclear cell (PMNC) infiltration.
A progressive visual defect and perceptive deafness fre-
quently occurs with increasing age. Joint symptoms man-
ifest as recurrent joint flares with or without severe ra-
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diologically evident modifications involving the growth
cartilage or bone epiphysis (fig. 1). In addition, common
morphological features (fig. 1), a shortening of distal
limbs, and growth retardation give a sibling-like resem-
blance between unrelated patients. Intrafamilial recur-
rence, although much rarer than sporadic cases, is sug-
gestive of an autosomal dominant inheritance pattern.
However, the small number of familial cases have until
now impeded a genomewide linkage approach. Recently,
several genes involved in recurrent inflammatory syn-
dromes, which also are associated with intermittent epi-
sodes of cutaneous rash, arthralgia, and fever, have been
localized and identified. These include the TNFRSF1A
gene on chromosome 12p13, associated with familial Hi-
bernian fever (also called “TNF-receptor–associated pe-
riodic syndrome” [MIM 142680]) (McDermott et al.
1999); the MEFV gene on chromosome 16p13.3, asso-
ciated with familial Mediterranean fever (FMF [MIM
249100]) (The French FMF Consortium 1997; The In-
ternational FMF Consortium 1997); the MVK gene on
chromosome 12q24, associated with hyper-IgD syndrome
(MIM 260920) (Drenth et al. 1999; Houten et al. 1999);
and the CIAS1 gene on chromosome 1q44, associated
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Figure 1 Typical CINCA syndrome features. A, Facial appear-
ance of patient 6 at age 12 years, with characteristic frontal bossing
and protruding eyes. B, Radiological bone and joint modifications.
Bilateral severe bone deformities of the knees of patient 7 at age 2.5
years, resulting in hard bony enlargement without any suggestion of
synovial thickening on palpation. Arrows show the growth cartilage
burst and increased irregular patellar opacity.
Table 1
CINCA Cases and Results of Mutations Analysis of CIAS1
Proband





1 Neonatal onset, skin lesion, chronic meningitis, joint inflammation,
sensory organ impairment, dysmorphy
T1718C F573S
2 Neonatal onset, skin lesion, chronic meningitis, joint inflammation,
sensory organ impairment, dysmorphy
C916A Q306L
3a Onset at age 6 mo, skin lesion, chronic meningitis, joint inflamma-
tion, sensory organ impairment, dysmorphy
C1307A T436N
3b Onset at age 3 years, joint inflammation, sensory organ impairment,
dysmorphy
C1307A T436N
4 Neonatal onset, skin lesion, joint inflammation, sensory organ im-
pairment, dysmorphy
A1073G H358R
5 Onset during the first year of life, skin lesion, chronic meningitis,
joint inflammation, sensory organ impairment, dysmorphy
T1985C M662T
6 Neonatal onset, skin lesion, chronic meningitis, joint inflammation,
sensory organ impairment, dysmorphy
G907A D303N
7 Neonatal onset, skin lesion, chronic meningitis, joint inflammation,
radiological severe arthropathy, sensory organ impairment,
dysmorphy
T926C F309S
a Precise clinical information was not available for the two patients from family 3 during the neonatal period or
for the affected fathers in families 3 and 6.
b Numbers represent the base location in the cDNA sequences, where base 1 is the first base of the second ATG
codon.
with the Muckle-Wells syndrome (MWS [MIM 191900])
and familial cold autoinflammatory syndrome (FCAS
[MIM 120100]) (Hoffman et al. 2001).
In the familial cases of CINCA syndrome that we have
investigated, disease segregation was compatible with
linkage to the CIAS1-containing genetic region on chro-
mosome 1 (data not shown) (Cuisset et al. 1999), a
finding that prompted us to search for mutations of
CIAS1 in patients with CINCA. We have therefore stud-
ied seven unrelated white families with classic features
of CINCA (table 1) and have sequenced the CIAS1 cod-
ing sequence (GenBank accession number AF427617),
to search for the presence of mutations. Both strands of
the CIAS1 coding sequence, as well as each exon/intron
flanking sequence, was screened by direct sequencing of
PCR fragments, through use of combinations of primer
pairs described elsewhere (Hoffman et al. 2001). In these
families, mutation analysis identified distinct missense
mutations, all located in CIAS1 exon 3 (table 1 and fig.
2). In family 1, a T1718C de novo transition appeared
in the proband, changing a phenylalanine into a serine
codon (F573S). A C916A transition (leading to Q306L)
was identified in the proband from family 2. In family
3, both patients and their affected father display a
C1307A transition, leading to a threonine-to-asparagine
codon change (T436N). A G907A transition changes an
aspartic acid (a negative acidic residue highly conserved
at this position among members of the NACHT sub-
family [Koonin and Aravind 2000]) into an asparagine
codon (D303N; fig. 2B) in patient 6 and in her affected
father. A nucleotide transition was also found in patient
4 (A1073G, leading to H358R), in patient 5 (T1985C,
leading to M662T), and in patient 7 (T926C, leading
to F309S); these appeared as de novo mutations in these
three probands. These mutations were not present in any
of the parents of patients with sporadic cases, in any
unaffected individual in these families (fig. 2A), or in
170 ethnically related healthy control individuals, which
excludes the possibility that these mutations are com-
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Figure 2 A, Mutation segregation in pedigrees of families with CINCA. Square symbols denote males; circles denote females; affected
individuals are denoted by blackened symbols, and segregating CIAS1 mutations are denoted by the capital letter M. In each pedigree, family
members from whom DNA samples were available for analysis are marked by an asterisk. Autosomal dominant inheritance of CINCA is
suggested by the segregation observed in families 3 and 6. B, Mutation locations on CIAS1 in three patients and domain structure of CIAS1.
Residues 1–90 form the N-terminal pyrin domain, residues 219–534 form the NBS/NACHT domain, and residues 740–991 form the C-terminal
leucine rich repeats. Shown at the bottom is the sequence of the NBS domain around the consensus motif-III Mg2-binding site (boxed) found
in the NACHT subfamily of NTPases (following Koonin and Aravind 2000) with the mutations (arrowheads) found in three families with
CINCA. h p hydrophobic residues; u p tiny residues; n p negatively charged residues; p p polar residues.
mon polymorphisms. No mutation could be identified
in an additional patient with a diagnosis of CINCA syn-
drome who presented with neonatal onset of skin le-
sions, joint inflammation, and radiologically severe ar-
thropathy but without detectable chronic meningitis at
the time of the study. Although this result does not rule
out the possibility that there is a mutation elsewhere in
the sequence that affects mRNA translation, this may
alternatively suggest either genetic heterogeneity of this
disease or the occurrence of an acquired form in this
sporadic case.
CIAS1 encodes cryopyrin, a protein composed of two
protein-protein interaction domains, an amino-terminal
pyrin-like domain, and a carboxy-terminal domain con-
taining leucine-rich repeats (“LLR” in fig. 2B) (Hoffman
et al. 2001). In addition, cryopyrin includes a central
nucleotide-binding site (NBS) domain that belongs to
the NACHT subfamily of NTPases, which is character-
ized by the presence of seven distinct characteristic con-
served motifs, including the ATP/GTPase-specific P loop
and the Mg2-binding site (Koonin and Aravind 2000).
Several other proteins from the CED4/Apaf1 family of
proteins (Zou et al. 1997), including members of the
caspase activation and recruitment domain family, share
the same domain architecture (Hlaing et al. 2001; Mar-
tinon et al. 2001; Miceli-Richard et al. 2001). This fam-
ily of proteins coordinates the assembly of signaling
complexes that regulate the activation of NF-kB, cyto-
kine processing, and apoptosis (Martin 2001). They are
thought to occupy a crucial position in stress-associated
signaling pathways that culminate in cell death or in-
flammatory responses. Accordingly, the pyrin domain
of CIAS1 (also known as “pyrin-containing Apaf1-like
protein 1” [PYPAF1]) was recently shown to interact
selectively with the pyrin domain of the apoptosis pro-
tein ASC, leading to the activation of NF-kB (Manji et
al. 2002), which suggests a function of CIAS1 related
to inflammation.
All of the observed mutations in patients with CINCA
fall within exon 3 of CIAS1; five of them modify the
region encoding the NBS/NACHT domain, with a clus-
ter of three mutations very close to the Mg2-coordi-
nating aspartate (D300) (fig. 2B) (Koonin and Aravind
2000; Falcon-Perez et al. 2001) and thus potentially dis-
rupting nucleotide binding-site function. Since this re-
gion is thought to contain binding sites for upstream
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Figure 3 Semiquantitative RT-PCR of CIAS1 mRNA expression in various tissues with b-actin levels shown below. RNAs (50ng) from
each tissue was reverse transcribed and PCR amplified by a one-step RT-PCR using the following oligonucleotides: 5′-TTGAAGAGGAGTGGAT-
GGGTT-3′ (sense on exon 2) and 5′-GATGGGTGGGTTTGGGTC-3′ (antisense on exon 3), which predict a 507-bp product of CIAS1. b-actin
oligonucleotides, 5′- TACCACTGGCATCGTGATGGACT-3′ (sense on exon 2) and 5′-TCCTTCTGCATCCTGTCGGCAAT-3′ (antisense on
exon 3), were used in the same conditions as a control for RNA integrity and RT efficiency. A negative control containing no input RNA was
also included.
regulators, mutations in this region may affect the con-
trol of NF-kB activation.
A previous study has shown that expression of CIAS1
is restricted to peripheral blood leukocytes (Hoffman et
al. 2001). Tissue expression of CIAS1 was examined,
and CIAS1 was found to be strongly expressed in the
PMNC, whereas it was undetectable or expressed at a
lower magnitude in B and T lymphoblasts, respectively
(fig. 3). Interestingly, high-level expression was also de-
tected in chondrocytes (fig. 3)—a provocative finding,
given the phenotype of patients with CINCA syndrome,
since most of the clinical features result from the dele-
terious effect of PMNC infiltration of various organs
and from manifestations such as growth retardation,
cartilage burst, epiphyseal anomalies, late closure of the
fontanel, and morphological anomalies (frontal bossing,
saddle-back nose), which suggest a cartilage target.
These data suggest that CIAS1 may function as an in-
ducer of apoptosis in these cells. Thus, in addition to its
role in NF-kB activation, CIAS1 may also be connected
to the apoptosis pathway. Of great interest are the recent
studies that highlight a potential dual role of NF-kB, as
an inducer both of proinflammatory mediators during
the onset of inflammation and of anti-inflammatory me-
diators and apoptosis during the resolution of inflam-
mation (Lawrence et al. 2001; Karin and Lin 2002). An
attractive hypothesis would be that mutations in the reg-
ulatory nucleotide-binding domain of CIAS1 affect the
NF-kB activation pathway in a way that leads to a de-
fective switching of NF-kB between these two functions.
This hypothesis would be in agreement with the in vivo
model of rat carageenin-induced acute inflammation, in
which inhibition of NK-kB during the resolution of in-
flammation protracts inflammatory responses and pre-
vents apoptosis (Lawrence et al. 2001).
The association of chronic inflammation with recur-
rent fever, cutaneous rash, and joint symptoms is a com-
mon characteristic of severe disorders within the group
of autoinflammatory diseases. However, CINCA syn-
drome is an original entity defined by neonatal onset
and a unique cluster of manifestations, including chronic
PMNC meningitis, as well as the severe and unique joint
manifestations, characterized by symmetrical epiphyse-
al and metaphyseal cartilage anomalies. These features
differentiate CINCA from FCAS (Zip et al. 1993) and
MWS (Muckle 1979), recently shown to result from mis-
sense mutations in the same exon of CIAS1 (Hoffman
et al. 2001). None of the mutations identified in the
patients with CINCA reported in the present study have
so far been associated with FCAS or MWS. The mu-
tations occur de novo in five of the seven patients with
CINCA syndrome, a higher proportion than that ob-
served in the families with FCAS and MWS that have
previously been reported (2/4). Although these data are
not statistically significant, the early onset and severity
of CINCA syndrome, which can be fatal in some pa-
tients, in comparison with the delayed and milder phe-
notype occurring in FCU/FCAS, may favor the occur-
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rence of de novo mutations. The analysis of a greater
number of patients with each condition is required to
validate this preliminary observation and to determine
whether disease expression strictly depends on the nature
and localization of the CIAS1 mutation, or whether it
is also influenced by still-undefined environmental or
genetic factors.
In conclusion, we show that CIAS1 mutations can
lead to very distinct phenotypes among the autoinflam-
matory diseases, including CINCA syndrome. Given the
peculiar phenotype observed in patients with CINCA,
in terms of PMNC activation and cartilage overgrowth,
the high level of expression of CIAS1 that we show to
be restricted to these two types of cells strongly supports
the hypothesis of a role of CIAS1 in apoptosis. Since
CIAS1 was recently shown in vitro to activate NF-kB,
we speculate that mutations in CIAS1 may disturb the
physiological balance between the proinflammatory and
proapoptotic function of NK-kB, by favoring the former.
Further studies will be necessary to better identify this
anti-inflammatory pathway. Its elucidation may provide
a potential new target for the treatment of inflammatory
disease.
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